WallStreetZenWallStreetZen

NASDAQ: ONCY
Oncolytics Biotech Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Oncolytics Biotech earnings were -$22.3M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest ONCY earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$5.6M, down 20.7% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, ONCY reported annual earnings of -$22.0M, with 5.5% growth.

ONCY earnings history

Current Revenue
$0.0
Current Earnings
-$22.0M
Current Profit Margin
0%

ONCY Return on Equity

Current Company
-225.2%
Current Industry
-2%
Current Market
34.1%
ONCY's Return on Equity (-225.2%)... subscribe to Premium to read more.
High Return on Equity Performance

ONCY undefined

Current Company
-114%
Current Industry
-0.4%
ONCY is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when ONCY announces earnings.

ONCY undefined

Current Company
-233.93%
Current Industry
5.9%
ONCY's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ONCY vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
ONCY-$21.94M-$22.33MN/A-$0.29
RNTX-$64.36M-$62.88MN/A-$3.51
CNTB-$14.75M-$15.63MN/A-$0.28
IRD-$57.52M-$57.53MN/A-$2.15
QNCX-$56.56M-$56.83MN/A-$1.31
View Top Biotech Stocks

Oncolytics Biotech Earnings Reports & History FAQ

What were Oncolytics Biotech's earnings last quarter?

On ONCY's earnings call on Invalid Date, Oncolytics Biotech (NASDAQ: ONCY) reported Q4 2024 earnings per share (EPS) of -$0.07, up 81.58% year over year. Total ONCY earnings for the quarter were -$5.57 million. In the same quarter last year, Oncolytics Biotech's earnings per share (EPS) was -$0.04.

If you're new to stock investing, here's how to buy Oncolytics Biotech stock.

Is Oncolytics Biotech profitable or losing money?

As of the last Oncolytics Biotech earnings report, Oncolytics Biotech is currently losing money. Oncolytics Biotech's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$22.02 million, a 5.53% increase year over year.

What was ONCY's earnings growth in the past year?

As of Oncolytics Biotech's earnings date in Invalid Date, Oncolytics Biotech's earnings has grown year over year. ONCY earnings in the past year totalled -$22.33 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.